BioNTech SE
@BioNTech_Group
At #BioNTech, we’re looking forward to #ASCO25, presenting oncology pipeline progress: mRNA cancer immunotherapies, ADCs, and next-gen immunomodulators and targeted therapies.
🗓 May 30 – June 3 | Chicago
📍 Booth #35165
#CancerResearch #ImmunoOncology #OncologyInnovation
🗓 May 30 – June 3 | Chicago
📍 Booth #35165
#CancerResearch #ImmunoOncology #OncologyInnovation
1 36